Literature DB >> 856077

The effect of the distal splenorenal shunt on hypersplenism.

D G Hutson, R Zeppa, J U Levi, E R Schiff, A S Livingstone, P Fink.   

Abstract

Twenty-four patients with leukopenia and/or thrombocytopenia improved these deficiencies after distal splenorenal shunts. The average white blood cell count for 23 neutropenic patients increased by an average 1000 cells/cu.mm p less than .01. The average platelet count for 13 thrombocytopenic patients increased by more than 40,000, p less than .02. Analysis of the data showed that patients older than 50 years, with a history of alcoholic liver disease and sinusoidal hypertension greater than 15mm Hg were most likely to correct leukocyte and platelet defects after distal splenorenal shunts.

Entities:  

Mesh:

Year:  1977        PMID: 856077      PMCID: PMC1396162          DOI: 10.1097/00000658-197705000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  11 in total

Review 1.  Surgical management of portal hypertension.

Authors:  S Bengmark
Journal:  Clin Gastroenterol       Date:  1975-05

Review 2.  Extrahepatic manifestations of cirrhosis.

Authors:  G A Martini
Journal:  Clin Gastroenterol       Date:  1975-05

3.  Experiences with portacaval anastomosis. Analysis of 104 elective end-to-side shunts for the prevention of recurrent hemorrhage from esophagogastric varices (1952 through 1961).

Authors:  L M ROUSSELOT; W F PANKE; R F BONO; A H MORENO
Journal:  Am J Med       Date:  1963-03       Impact factor: 4.965

4.  Portal hypertension.

Authors:  C M LEEVY; G R CHERRICK; C S DAVIDSON
Journal:  N Engl J Med       Date:  1960-03-03       Impact factor: 91.245

5.  Lateral portacaval anastomosis for portal hypertension: long term results in 58 patients with intrahepatic portal bed block and 7 patients with extrahepatic portal bed block.

Authors:  T B PATTON; C G JOHNSTON; C LYONS; P JORDAN
Journal:  Am J Gastroenterol       Date:  1959-09       Impact factor: 10.864

6.  Peripheral blood picture after operation for portal hypertension.

Authors:  A I S MACPHERSON; J INNES
Journal:  Lancet       Date:  1953-06-06       Impact factor: 79.321

7.  Portal hypertension, congestive splenomegaly, and portacaval shunt.

Authors:  P W MORRIS; T B PATTON; J A BALINT; B I HIRSCHOWITZ
Journal:  Gastroenterology       Date:  1962-05       Impact factor: 22.682

8.  The effect of portacaval shunt on hypersplenism.

Authors:  W R Felix; R M Myerson; B Sigel; E B Perrin; F C Jackson
Journal:  Surg Gynecol Obstet       Date:  1974-12

Review 9.  Surgery and portal hypertension.

Authors:  C G Child; J G Turcotte
Journal:  Major Probl Clin Surg       Date:  1964

Review 10.  Increased splenic pooling and the pathogenesis of hypersplenism.

Authors:  J H Jandl; R H Aster
Journal:  Am J Med Sci       Date:  1967-04       Impact factor: 2.378

View more
  16 in total

1.  Ebstein's anomaly associated with splenomegaly and reversible hypersplenism.

Authors:  M R Bennett; M F Shiu
Journal:  Br Heart J       Date:  1991-04

2.  Reversal of hypersplenism following orthotopic liver transplantation.

Authors:  K Yanaga; A G Tzakis; M Shimada; W E Campbell; J W Marsh; A C Stieber; L Makowka; S Todo; R D Gordon; S Iwatsuki
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

3.  [The distal spleno-renal anastomosis of Warren (author's transl)].

Authors:  G P Marzoli; S Vesentini; F Frasson; C Fugazzola; G Mangiante
Journal:  Langenbecks Arch Chir       Date:  1979-05-02

4.  Red cell survival in patients with nonalcoholic liver cirrhosis before and after distal splenorenal shunt.

Authors:  M Nishiwaki; H Ashida; A Nishioka; J Utsunomiya
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

5.  Selective variceal decompression after splenectomy or splenic vein thrombosis. With a note on splenopancreatic disconnection.

Authors:  W D Warren; W J Millikan; J M Henderson; M E Rasheed; A A Salam
Journal:  Ann Surg       Date:  1984-06       Impact factor: 12.969

6.  Splenectomy for splenomegaly and secondary hypersplenism.

Authors:  W W Coon
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

7.  Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?

Authors:  N Jabbour; A Zajko; P Orons; W Irish; J J Fung; R R Selby
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

8.  Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis.

Authors:  Amir A Qamar; Norman D Grace; Roberto J Groszmann; Guadalupe Garcia-Tsao; Jaime Bosch; Andrew K Burroughs; Cristina Ripoll; Rie Maurer; Ramon Planas; Angels Escorsell; Juan Carlos Garcia-Pagan; David Patch; Daniel S Matloff; Robert Makuch; Gabriel Rendon
Journal:  Clin Gastroenterol Hepatol       Date:  2009-03-10       Impact factor: 11.382

9.  Selective shunt versus nonshunt surgery for management of both schistosomal and nonschistosomal variceal bleeders.

Authors:  F A Ezzat; K M Abu-Elmagd; M A Aly; O M Fathy; N A el-Ghawlby; A M el-Fiky; M H el-Barbary
Journal:  Ann Surg       Date:  1990-07       Impact factor: 12.969

10.  Effect of portacaval anastomosis on hypersplenism.

Authors:  M G Mutchnick; E Lerner; H O Conn
Journal:  Dig Dis Sci       Date:  1980-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.